EP0179070A1 - Duftstoffe auf basis von hyaluronsäure/hyaluronaten - Google Patents

Duftstoffe auf basis von hyaluronsäure/hyaluronaten

Info

Publication number
EP0179070A1
EP0179070A1 EP19840904297 EP84904297A EP0179070A1 EP 0179070 A1 EP0179070 A1 EP 0179070A1 EP 19840904297 EP19840904297 EP 19840904297 EP 84904297 A EP84904297 A EP 84904297A EP 0179070 A1 EP0179070 A1 EP 0179070A1
Authority
EP
European Patent Office
Prior art keywords
hyaluronic acid
fragrance
salt form
composition
naha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19840904297
Other languages
English (en)
French (fr)
Inventor
James W. Bracke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnostic Inc
Original Assignee
Diagnostic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Inc filed Critical Diagnostic Inc
Publication of EP0179070A1 publication Critical patent/EP0179070A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q13/00Formulations or additives for perfume preparations

Definitions

  • This invention relates generally to the use of hyaluroni ⁇ acid/hyaluronate as a means for achieving molecular encapsulation of various substances.
  • the inven ⁇ tion specifically relates to the use of hyaluronic acid/ hyaluronate as a molecular encapsulant (fixative) for various fragrance products.
  • a fixative in the perfume art is a substance, which, when combined with a fragrance or a cosmetic product including a fragrance, retards the rate of evaporation of the fragrance thus rendering its odor more persistent.
  • a fragrance After a fragrance has been formulated and compounded, it is usually added to a cosmetic product, e.g., alcoholic fragrance solutions and aerosols including perfumes, toilet waters, colognes or bath oils, creams, gels, emollients, lotions, air fresheners, and deoderants .
  • a fragrance may include various perfume oils and mixtures of a wide variety of material (animal and plant) and synthetic fragrant substances.
  • Such fragrant substan ⁇ ces are typically selected from a wide variety of essential oils, absolutes, isolates, expressed oils, animal secre ⁇ tions, resins, gums, balsams, exudations and synthetic aliphatic and aromatic chemicals.
  • fragrance compositions all cos ⁇ metic products and fragrant compositions will be referred to herein generally as fragrance compositions .
  • hyaluronic acid/hyaluronate in fragrance compositions will add other benefits to those preparations in addition to the entrapment of scent.
  • fragrances cause irritation of the skin of some individuals to which those scents are applied.
  • the natural composition of hyaluronic acid/ hyaluronate in combination with the tendency to bind fragrance will reduce the exposure of sensitive skin to direct contact with a fragrance, thus reducing the opportunity for irritation to develop.
  • Hyaluronic acid (hereinafter referred to as "HA” . as well as its salts , such as sodium hyaluronate (hereinafter referred to as "NaHA” ; NaHA is also used to refer generally to any salt form of HA herein) is a known, naturally occuring high viscosity glycosaminoglycan having alternating p 1-3 glucuronidic and /3 1-4 glucosaminidic bonds. It may also be described as a polysaccharide com ⁇ posed of alternate A -D-glucopyranosyluronic acid and 2-acetamido-2-deoxy- ⁇ -D-glucopyranosyl units linked (1 - 3) and (1 - 4), respectively.
  • the molecular weight of this material is generally within the range of 50,000 to 8,000,000 (although there are reports of HA having molecu ⁇ lar weights as high as 13,000,000) depending on the source, method of isolation and method of determination. Typically, it exists in either the acid or the salt form either of which may be used in this invention.
  • animal tissue e.g. in umbilical cord, vitreous humor, synovial fluid, rooster combs, body joints, group A and C hemolytic streptococci and in human skin .
  • HA muccopolysaccharide
  • U.S. Patent 2,975,104 describes the biosynthesis of HA, as does British Patent 1,557,755.
  • Kjems and Lebeck in Acta Path . microbiol . scand. , Section B. , 84t_: 162-164 (1976) describe the strep- tococcal biosynthesis of a relatively low molecular weight HA.
  • HA isolation and characterization of HA is described in Meyer et al, J. Biol . Chem. 107, 629 (1934); J. Biol. Chem., 114, 689 (1936); Balazs, Fed. Proc. 17, 1086 (1958); Laurent et al ; Biochim. Biophys . Acta 42,476 (1960).
  • the structure of HA was elucidated by Weissman et al, J. Am. Chem. Soc. 76, 1753 (1954) and Meyer, Fed. Proc. 17, 1075 (1958).
  • Sodium hyaluronate the salt form of HA
  • HA Sodium hyaluronate
  • Pharmacia AB Uppsala, Sweden
  • AMVISC Med-Chem Products, Inc. (236 West Cummings Park, Woburn, MA 01801) from rooster combs
  • HYALURE TM produced in various grades including a cosmetic grade, by Diagnostic, Inc., 1955 West County Road B2, St., Paul, Minnesota 55113 using microbial fermentation.
  • This invention provides the fixation of various substances by means of HA/NaHA and its ability for molecu ⁇ lar encapsulation. It especially provides improved fra ⁇ grance compositions which exhibit prolonged persistence of the fragrance. This is believed due to the entrapment of the fragrant components of the composition by the HA or NaHA, which is included in the compositions according to this invention. The same persistent fragrance effect is obtained when either HA or NaHA is included in the fragrant compositio . Description of the Preferred Embodiment
  • HA or NaHA used for the purposes of this invention may be obtained or prepared in any variety of ways, as referred to hereinabove.
  • the HA is used in an aqueous solution form.
  • aqueous solution can be prepared in any relative amounts, .005% - 1% NaHA, balance water, being most typi ⁇ cal, the 1% solution being quite viscous (like a rich cream) .
  • Perfume as an example of a fragrance com ⁇ position, is usually composed of a solvent such as alcohol plus a concentrated fragrant essence.
  • the NaHA solution may be mixed with the perfume or any other fragrant com ⁇ position in any relative amount which is not particularly critical. The amount will be determined by the particular objective intended. For example, small amounts may be used to enable one to provide a persistent perfume which main ⁇ tains its normal appearance. Larger amounts may be used to increase persistence and to increase the viscosity of the perfume.
  • KEORA Jean Couturier
  • test results A fresh cotton swab was dipped into the selected test perfume solution (A or B above), wiped on the side of the container neck four times, and a two inch streak placed on the inside of the test subjects' wrist at the beginning of the work day.
  • the opposite wrist received the control solution of that subjects' scent choice (A or B above).
  • the subjects were asked to monitor their wrists to deter ⁇ mine if any difference could be detected during the course of the work day. The subjects did not know the nature of the solutions placed on each wrist.
  • test subjects eight (50%) of the test subjects could distinguish no difference between either the control or the test arm and after the test could't determine scent or odor endpoints of either arm.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
EP19840904297 1984-04-23 1984-11-13 Duftstoffe auf basis von hyaluronsäure/hyaluronaten Withdrawn EP0179070A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60281384A 1984-04-23 1984-04-23
US602813 1984-04-23

Publications (1)

Publication Number Publication Date
EP0179070A1 true EP0179070A1 (de) 1986-04-30

Family

ID=24412903

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19840904297 Withdrawn EP0179070A1 (de) 1984-04-23 1984-11-13 Duftstoffe auf basis von hyaluronsäure/hyaluronaten

Country Status (4)

Country Link
EP (1) EP0179070A1 (de)
AU (1) AU3619984A (de)
FI (1) FI854930A (de)
WO (1) WO1985004803A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724319B1 (fr) 1994-09-08 1996-10-18 Oreal Utilisation d'un compose vegetal pour la fixation d'un parfum dans une composition cosmetique et/ou dermatologique
EP3103431A1 (de) 2015-06-12 2016-12-14 The Procter and Gamble Company Duftzusammensetzungen und verwendungen davon
EP3103523A1 (de) 2015-06-12 2016-12-14 The Procter and Gamble Company Saugfähiger artikel mit duftstoffzusammensetzung
US10501706B2 (en) 2015-06-12 2019-12-10 The Procter & Gamble Company Fragrance compositions and uses thereof
EP3743163A1 (de) 2018-02-07 2020-12-02 Coty, Inc. Gewürzzusammensetzungen und verwendungen davon
EP4161474A1 (de) 2020-06-05 2023-04-12 Coty Inc. Duftzusammensetzung mit einer duftkomponente und einem geruchsfreien duftmodulator
EP4408382A1 (de) 2021-09-30 2024-08-07 Coty Inc. Duftstoffzusammensetzungen auf polyurethanbasis
EP4426262A1 (de) 2021-11-04 2024-09-11 Coty Inc. Ethanolfreies duftchassis
FR3143998A1 (fr) 2022-12-21 2024-06-28 Coty Inc. Compositions de parfum et leurs utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4303676A (en) * 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO8504803A1 *

Also Published As

Publication number Publication date
FI854930A0 (fi) 1985-12-12
FI854930A (fi) 1985-12-12
AU3619984A (en) 1985-11-15
WO1985004803A1 (en) 1985-11-07

Similar Documents

Publication Publication Date Title
US5153230A (en) Topical skin cream composition
US4973473A (en) Skin care preparation
KR100230830B1 (ko) 흡취제로서 수용성 아연염을 함유 하는 탈취용조성물
GB2099826A (en) Hyaluronate based compositions and cosmetic formulations containing same
US5169631A (en) Topical antimicrobial composition and uses
US3463862A (en) Albumin containing comsmetic lotion
JPS62205008A (ja) 化粧品等の添加剤
US4268526A (en) Cosmetic cream formulation
GB2194888A (en) Composition for inducing and stimulating hair growth
EP0179070A1 (de) Duftstoffe auf basis von hyaluronsäure/hyaluronaten
KR930016107A (ko) 박테리아 부착을 억제하는 물질을 함유하는 탈취제 조성물, 이의 사용 방법 및 박테리아 부착을 억제하는 물질의 결정 방법
JPS61180705A (ja) 皮膚外用組成物
JPH0768114B2 (ja) 入浴剤
US4263274A (en) Antiperspirant compositions and methods
KR102026365B1 (ko) 우리딘 및 활성촉진 복합체를 포함하는 화장료 조성물
JPH10182411A (ja) 皮膚外用剤
JPH0521085B2 (de)
JPS59231013A (ja) 脱臭化粧品剤
CN109498520A (zh) 去屑组合物、洗发水及其制备方法
JP2678138B2 (ja) 牛乳を含むo/w型エマルジョン化粧料組成物
JP2003238375A (ja) 香料組成物及び化粧料
US4761278A (en) Ladies aftershave preparation and method for its manufacture
JPS59186911A (ja) 頭髪化粧料
JPH1095704A (ja) 外用に適する組成物
JPS5936882B2 (ja) 口腔用組成物

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB LI NL SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Withdrawal date: 19860401

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BRACKE, JAMES, W.